| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | PAO and PFO | Common Stock | 146,506 | $354,881 | $2.42 | 10 Feb 2026 | Direct |
| Zentalis Pharmaceuticals, Inc. | PAO and PFO | Stock Option (Right to Buy) | 100,000 | 08 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | 06 Feb 2026 | 3 | -$97,557 | 4 | PAO and PFO | 10 Feb 2026, 21:10 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 02 Feb 2026 | 2 | -$7,875 | 4 | PAO and PFO | 04 Feb 2026, 20:27 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 08 Jan 2026 | 1 | $0 | 4 | PAO and PFO | 09 Jan 2026, 20:36 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 03 Feb 2025 | 3 | -$4,476 | 4 | PAO and Interim PFO | 05 Feb 2025, 18:33 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 04 Oct 2024 | 1 | -$5,098 | 4 | Principal Accounting Officer | 04 Oct 2024, 18:01 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 05 Apr 2024 | 0 | $0 | 3 | Principal Accounting Officer | 11 Apr 2024, 07:02 |